Hot Features
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial de... Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.06 | -1.68539325843 | 3.56 | 3.655 | 3.4 | 10620 | 3.54713352 | CS |
| 4 | -0.1 | -2.77777777778 | 3.6 | 3.69 | 3.209 | 10334 | 3.53220057 | CS |
| 12 | -0.26 | -6.91489361702 | 3.76 | 4.31 | 3.209 | 10049 | 3.75309745 | CS |
| 26 | -1.24 | -26.1603375527 | 4.74 | 6.41 | 3.209 | 20619 | 4.65886594 | CS |
| 52 | -4.27 | -54.954954955 | 7.77 | 11.6779 | 3.209 | 47932 | 7.19152788 | CS |
| 156 | 0.85 | 32.0754716981 | 2.65 | 11.6779 | 1.53 | 48774 | 6.25770788 | CS |
| 260 | -1.98 | -36.1313868613 | 5.48 | 12.32 | 1.53 | 265367 | 8.9685029 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.